Cargando…
KRAS Inhibitor that Simultaneously Inhibits Nucleotide Exchange Activity and Effector Engagement
[Image: see text] We describe a small molecule ligand ACA-14 (2-hydroxy-5-{[(2-phenylcyclopropyl) carbonyl] amino} benzoic acid) as an initial lead for the development of direct inhibitors of KRAS, a notoriously difficult anticancer drug target. We show that the compound binds to KRAS near the switc...
Autores principales: | Pagba, Cynthia V., Gupta, Amit K., Naji, Ali K., van der Hoeven, Dharini, Churion, Kelly, Liang, Xiaowen, Jakubec, Jacob, Hook, Magnus, Zuo, Yan, Martinez de Kraatz, Marisela, Frost, Jeffrey A., Gorfe, Alemayehu A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125367/ https://www.ncbi.nlm.nih.gov/pubmed/37101428 http://dx.doi.org/10.1021/acsbiomedchemau.2c00045 |
Ejemplares similares
-
Discovery of High-Affinity Noncovalent Allosteric
KRAS Inhibitors That Disrupt Effector Binding
por: McCarthy, Michael J., et al.
Publicado: (2019) -
Small-Molecule Inhibition of KRAS through Conformational
Selection
por: Pagba, Cynthia V., et al.
Publicado: (2023) -
KRAS Ubiquitination at Lysine 104 Retains Exchange Factor Regulation by Dynamically Modulating the Conformation of the Interface
por: Yin, Guowei, et al.
Publicado: (2020) -
Targeting plasma membrane phosphatidylserine content to inhibit oncogenic KRAS function
por: Kattan, Walaa E, et al.
Publicado: (2019) -
vhp Is a Fibrinogen-Binding Protein Related to vWbp in Staphylococcus aureus
por: Thomas, Sheila, et al.
Publicado: (2021)